Case Studies - Real Regulatory

Preparation of an EU regulatory strategy plan for a US client

Adaptation of IND to IMPD for submitting in EU countries

Application for EU advanced therapy medicinal product (ATMP) classification and orphan drug designation (ODD)

Converting a 505(b)(2) NDA from the United States into a European MAA